Press release
Role Of Precision Medicine In Driving The RNA Sequencing Market: A Key Factor Shaping the Future of the Ribonucleic Acid (RNA) Sequencing Market in 2025
Ribonucleic Acid (RNA) Sequencing Market
The growing focus on precision medicine is expected to stimulate the growth of the RNA sequencing market. Precision medicine, which tailors treatments based on individual genetic, environmental, and lifestyle factors, is gaining traction. RNA sequencing helps analyze gene expression and identify medical conditions, advancing personalized treatment options. In February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 novel therapies for rare diseases in 2023, up from six in 2022. The focus on precision medicine is driving the RNA sequencing market.
Get Your Ribonucleic Acid (RNA) Sequencing Market Report Here:
https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report
What growth opportunities are expected to drive the ribonucleic acid (rna) sequencing market's CAGR through 2034?
The ribonucleic acid (RNA) sequencing market has seen exponential growth in recent years. It will increase from $3.25 billion in 2024 to $3.98 billion in 2025, reflecting a CAGR of 22.7%. The growth is driven by increased drug development activities, the rising prevalence of genetic disorders, and growing demand for personalized medicine and biomarker profiling.
The RNA sequencing market is poised for exponential growth, projected to hit $8.91 billion by 2029 with a CAGR of 22.3%. Growth will be driven by a rise in demand for rapid, accurate disease diagnosis, increased adoption of real-time PCR, and a surge in demand for on-site diagnostic testing. Trends will include advancements in disease detection, drug discovery, and next-generation sequencing technologies, alongside the development of lab-on-a-chip platforms and other molecular diagnostic solutions.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp
What are the emerging trends shaping the future of the ribonucleic acid (rna) sequencing market?
Companies operating in the ribonucleic acid (RNA) sequencing market are advancing RNA next-generation sequencing assays to improve patient care through precision medicine and data-driven insights. For example, in June 2023, Tempus, a US-based precision medicine company, launched the Tempus xR RNA next-generation sequencing assay designed for solid tumors. This assay provides a comprehensive analysis of the entire transcriptome, helping clinicians identify significant genetic alterations like fusions in over 100 genes, and altered splicing in MET Exon 14 and EGFRvIII.
Which growth-oriented segments of the ribonucleic acid (rna) sequencing market are leading the industry's development?
The ribonucleic acid (RNA) sequencing market covered in this report is segmented -
1) By Product Type: Instruments, Reagents And Kits, Software
2) By Technology: Single Molecule Based Sequencing, Sequence By Synthesis Technology, Nanopore Sequencing Technology, Ion Torrent Semiconductor Sequencing
3) By Applications: Diagnostics, Drug Discovery, Translational Medicine, Other Applications
4) By End User: Research And Academia, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Instruments: Next-Generation Sequencers, Microarray Instruments, Single-Cell Rna Sequencing Instruments
2) By Reagents And Kits: Rna Extraction Kits, Rna Sequencing Kits, Library Preparation Kits
3) By Software: Data Analysis Software, Data Management Software, Bioinformatics Software
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15665
What regions are leading the charge in the ribonucleic acid (rna) sequencing market?
North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the ribonucleic acid (rna) sequencing market?
Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Genomics Inc., Natera Inc., Myriad Genetics Inc., BGI Genomics Co Ltd., Takara Bio Inc., Cepheid, NeoGenomics Laboratories Inc., Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., Standard BioTools Inc., Ambry Genetics Corporation, Biocartis SA, CD Genomics
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15665&type=smp
What Is Covered In The Ribonucleic Acid (RNA) Sequencing Global Market Report?
•Market Size Forecast: Examine the ribonucleic acid (rna) sequencing market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the ribonucleic acid (rna) sequencing market for a structured understanding.
•Key Players Overview: Analyze major players in the ribonucleic acid (rna) sequencing market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the ribonucleic acid (rna) sequencing market.
•Segment Contributions: Evaluate how different segments drive overall growth in the ribonucleic acid (rna) sequencing market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the ribonucleic acid (rna) sequencing market.
•Industry Challenges: Identify potential risks and obstacles affecting the ribonucleic acid (rna) sequencing market.
•Competitive Landscape: Review strategic developments in the ribonucleic acid (rna) sequencing market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Role Of Precision Medicine In Driving The RNA Sequencing Market: A Key Factor Shaping the Future of the Ribonucleic Acid (RNA) Sequencing Market in 2025 here
News-ID: 3934422 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
